Latest filing published 22 Jul 2020 for Adverum Biotechnologies, Inc., €21k.
Filing timeline
BuySaleInsider track record
Mehdi Gasmi: trading record in brief
Mehdi Gasmi discloses dealings in Adverum Biotechnologies, Inc. to SEC (Form 4). In total, 78 filings cover trades dated from 7 April 2015 to 20 July 2020.
No open-market purchase appears, only 31 sales worth €2.7M. The rest of the record consists of 23 share grants and 24 option exercises. 2020 to date brings no purchases and 17 sales.
On 22 July 2020 came the latest disclosure, an option exercise for €21k in Adverum Biotechnologies, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mehdi Gasmi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$4.800.5% of flowCommon StockSEC:0001209191-20-043426:0
- 5,000 shares@ US$17.601.8% of flowCommon StockSEC:0001209191-20-043426:1
- 23,605 shares@ US$4.802.3% of flowCommon StockSEC:0001209191-20-038635:0
- 23,605 shares@ US$25.0612.2% of flowCommon StockSEC:0001209191-20-038635:1
- 268 shares@ US$4.800.0% of flowCommon StockSEC:0001209191-20-037769:0
- 268 shares@ US$25.010.1% of flowCommon StockSEC:0001209191-20-037769:1
- 11,127 shares@ US$4.801.1% of flowCommon StockSEC:0001209191-20-037769:2
- 11,127 shares@ US$25.015.8% of flowCommon StockSEC:0001209191-20-037769:3
- 10,000 shares@ US$4.801.0% of flowCommon StockSEC:0001209191-20-037339:0
- 5,000 shares@ US$21.012.2% of flowCommon StockSEC:0001209191-20-037339:1
- 1,416 shares@ US$21.930.6% of flowCommon StockSEC:0001209191-20-037339:2
- 3,425 shares@ US$23.001.6% of flowCommon StockSEC:0001209191-20-037339:3
- 159 shares@ US$23.590.1% of flowCommon StockSEC:0001209191-20-037339:4
- 1,401 shares@ US$4.800.1% of flowCommon StockSEC:0001209191-20-031872:0
- 1,401 shares@ US$20.010.6% of flowCommon StockSEC:0001209191-20-031872:1
- 3,599 shares@ US$4.800.4% of flowCommon StockSEC:0001209191-20-031872:2
- 3,599 shares@ US$20.021.5% of flowCommon StockSEC:0001209191-20-031872:3
- 88,496 shares0Common StockSEC:0001209191-20-031045:0
- 10,000 shares@ US$4.801.0% of flowCommon StockSEC:0001209191-20-031047:0
- 10,000 shares@ US$16.263.5% of flowCommon StockSEC:0001209191-20-031047:1
- 25,000 shares@ US$4.802.6% of flowCommon StockSEC:0001209191-20-031047:2
- 25,000 shares@ US$20.0310.8% of flowCommon StockSEC:0001209191-20-031047:3
- 5,000 shares@ US$4.800.5% of flowCommon StockSEC:0001209191-20-031047:4
- 4,700 shares@ US$18.111.8% of flowCommon StockSEC:0001209191-20-031047:5
- 300 shares@ US$19.030.1% of flowCommon StockSEC:0001209191-20-031047:6
25 of 73 declarations